Clinical trials
Phase 1 Prediabetic State trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2016 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 6 |
| Beth Israel Deaconess Medical Center | 1 |
| Charles George VA Medical Center | 1 |
| Mayo Clinic | 1 |
| Philip Kern | 1 |
| Sanofi | 1 |
| Stanford University | 1 |
| Truway Health, Inc. | 1 |
| University of California, San Diego | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 17 |
| Insulin Resistance | 8 |
| Obesity | 8 |
| Diabetes Mellitus | 6 |
| Hyperinsulinism | 6 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Metabolic Syndrome | 4 |
| Glucose Intolerance | 3 |
| Overweight | 3 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.